Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.4B | 4.9B | 3.8B | 3.4B |
Cost of revenue | 2.9B | 4.2B | 3.3B | 3.0B |
Gross profit | 504M | 681M | 475M | 446M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 189M | 236M | 178M | 166M |
Operating income | -58M | 69M | -51M | -39M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | -98M | 30M | -94M | -83M |
Tax provision | -22M | 10M | -21M | -16M |
Net income | -77M | 20M | -74M | -67M |
Basic EPS | -0.4 | 0.1 | -0.4 | -0.4 |
Diluted EPS | -0.4 | 0.1 | -0.4 | -0.4 |
Basic average shares | 175.3M | 175.3M | 175.3M | 175.3M |
Diluted average shares | 175.3M | 175.3M | 175.3M | 175.3M |
EBITDA | 42M | 165M | 48M | 56M |
Net income from continuing op. | -98M | 30M | -94M | -83M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |